Discussion
Diagnosis With Brief Discussion
- Diagnosis
- IgG4-Related Disease
- Radiologic Findings
- Figs 1-3. Lung window images of contrast-enhanced chest CT scans show multiple irregular shaped subpleural lung nodules in both lungs, along with subpleural patchy ground glass opacities in both lower lobes.
Figs 4 and 5. Mediastinal window images of contrast-enhanced chest CT scans show mildly enlarged upper paratracheal and right hilar lymph nodes.
- Brief Review
- Upper abdominal CT revealed a diffusely enlarged pancreas with peripancreatic fluid, suggestive of pancreatitis. Considering both chest and upper abdominal CT findings, IgG4-related disease (IgG4-RD) was highly suspected. The patient's serum IgG4 level was elevated to 1234 mg/dL (normal range: 3.9–86.4 mg/dL). Histopathologic examination of an ampulla of Vater biopsy demonstrated significant lymphoplasmacytic infiltration, a moderate number of eosinophils, and phlebitis. Immunohistochemistry revealed plasma cell infiltration, with an IgG4-positive to IgG-positive plasma cell ratio greater than 40%. Lung lesions and pancreatitis improved with glucocorticoid therapy.
IgG4-related disease is an immune-mediated fibroinflammatory condition characterized by dense lymphoplasmacytic infiltrates rich in IgG4-positive plasma cells, typically accompanied by storiform fibrosis, obliterative phlebitis, and elevated serum IgG4 levels. It can affect virtually any organ. Thoracic involvement occurs in approximately 40% of IgG4-RD cases and is part of a systemic, multi-organ presentation that may include the pancreas, salivary glands, bile ducts, and kidneys.
Thoracic manifestations of IgG4-RD are diverse and heterogeneous, often mimicking lung cancer, malignant lymphoma, infection, sarcoidosis, or other systemic autoimmune diseases, which may delay diagnosis. The most common radiologic findings in thoracic IgG4-RD are mediastinal lymphadenopathy (50–80%) and peribronchovascular interstitial thickening (60%). Pulmonary manifestations vary and may include peribronchovascular interstitial thickening, nodules or masses, ground-glass opacities, interstitial lung abnormalities, segmental or lobar consolidation, and cavities or cysts.
Treatment is recommended for all symptomatic patients. Immunosuppressive therapy is the mainstay of treatment, with corticosteroids as the first-line option. Steroid non-responsiveness is rare (<5%), but relapse after tapering is common (60–80%). In steroid-refractory cases, other immunosuppressants such as rituximab, azathioprine, or mycophenolate mofetil may be considered. For localized disease, such as a pulmonary nodule or inflammatory pseudotumor, surgical excision may be an option.

- References
- 1. Stone JH et al. IgG4-related disease. N Engl J Med. 2012;366:539-551.
2. Muller R et al. Thoracic manifestations of IgG4-related disease. Respirology 2023; 28:120-131
- Keywords